# Clinical Study Sources

This document contains full citations and links to all clinical studies referenced on the CONKA ingredients page. All studies are peer-reviewed and indexed in PubMed.

---

## CONKA Flow (Formula 01) Ingredients

### 1. Lemon Balm (Melissa officinalis)

#### Study 1:

**Kennedy DO, Little W, Haskell CF, Scholey AB.** Anxiolytic effects of a combination of Melissa officinalis and Valeriana officinalis during laboratory induced stress. _Phytother Res._ 2006 Feb;20(2):96-102.

- **PMID:** [16444660](https://pubmed.ncbi.nlm.nih.gov/16444660/)
- **DOI:** [10.1002/ptr.1787](https://doi.org/10.1002/ptr.1787)
- **Study Design:** Randomized, double-blind, placebo-controlled, cross-over
- **Participants:** 24 healthy volunteers
- **Key Finding:** The 600mg dose ameliorated negative effects of stress on anxiety ratings

#### Study 2:

**Kennedy DO, Wake G, Savelev S, Tildesley NTJ, Perry EK, Wesnes KA, Scholey AB.** Modulation of mood and cognitive performance following acute administration of single doses of Melissa officinalis (Lemon balm) with human CNS nicotinic and muscarinic receptor-binding properties. _Neuropsychopharmacology._ 2003 Oct;28(10):1871-81.

- **PMID:** [12888775](https://pubmed.ncbi.nlm.nih.gov/12888775/)
- **DOI:** [10.1038/sj.npp.1300230](https://doi.org/10.1038/sj.npp.1300230)
- **Study Design:** Randomized, placebo-controlled, double-blind, balanced crossover
- **Participants:** 20 healthy young adults
- **Duration:** Single doses with 7-day intervals
- **Key Finding:** The highest dose (1600mg) improved memory performance and increased calmness at all post-dose time points

---

### 2. Turmeric / Curcumin (Curcuma longa)

#### Study 1:

**Small GW, Siddarth P, Li Z, Miller KJ, Ercoli L, Emerson ND, et al.** Memory and Brain Amyloid and Tau Effects of a Bioavailable Form of Curcumin in Non-Demented Adults: A Double-Blind, Placebo-Controlled 18-Month Trial. _Am J Geriatr Psychiatry._ 2018 Mar;26(3):266-277.

- **PMID:** [29246725](https://pubmed.ncbi.nlm.nih.gov/29246725/)
- **DOI:** [10.1016/j.jagp.2017.10.010](https://doi.org/10.1016/j.jagp.2017.10.010)
- **Study Design:** Randomized, double-blind, placebo-controlled trial
- **Participants:** 40 non-demented adults (age 51-84 years)
- **Duration:** 18 months
- **Key Finding:** Daily oral Theracurmin improved memory (ES=0.63, p=0.002), attention (ES=0.96, p<0.0001), and reduced brain amyloid and tau accumulation

#### Study 2:

**Rainey-Smith SR, Brown BM, Sohrabi HR, Shah T, Goozee KG, Gupta VB, Martins RN.** Curcumin and Cognition: A Randomised, Placebo-Controlled, Double-Blind Study of Community-Dwelling Older Adults. _Br J Nutr._ 2016 Feb;115(12):2106-13.

- **PMID:** [26878105](https://pubmed.ncbi.nlm.nih.gov/26878105/)
- **DOI:** [10.1017/S0007114515003579](https://doi.org/10.1017/S0007114515003579)
- **Study Design:** Randomized, placebo-controlled, double-blind
- **Participants:** 60 community-dwelling older adults
- **Duration:** 12 months
- **Key Finding:** Curcumin supplementation significantly improved working memory, reduced fatigue, and improved mood compared to placebo

---

### 3. Ashwagandha (Withania somnifera)

#### Study 1:

**Chandrasekhar K, Kapoor J, Anishetty S.** A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. _Indian J Psychol Med._ 2012 Jul;34(3):255-62.

- **PMID:** [23439798](https://pubmed.ncbi.nlm.nih.gov/23439798/)
- **PMCID:** [PMC3573577](https://pmc.ncbi.nlm.nih.gov/articles/PMC3573577/)
- **DOI:** [10.4103/0253-7176.106022](https://doi.org/10.4103/0253-7176.106022)
- **Study Design:** Prospective, randomized, double-blind, placebo-controlled
- **Participants:** 64 subjects with history of chronic stress
- **Duration:** 60 days
- **Key Finding:** Significant reduction in stress scores (P<0.0001) and serum cortisol levels (P=0.0006)

#### Study 2:

**Salve J, Pate S, Debnath K, Langade D.** Adaptogenic and Anxiolytic Effects of Ashwagandha Root Extract in Healthy Adults: A Double-blind, Randomized, Placebo-controlled Clinical Study. _Cureus._ 2019 Dec 25;11(12):e6466.

- **PMID:** [32021735](https://pubmed.ncbi.nlm.nih.gov/32021735/)
- **PMCID:** [PMC6979308](https://pmc.ncbi.nlm.nih.gov/articles/PMC6979308/)
- **DOI:** [10.7759/cureus.6466](https://doi.org/10.7759/cureus.6466)
- **Study Design:** Double-blind, randomized, placebo-controlled
- **Participants:** 58 healthy adults
- **Duration:** 8 weeks
- **Key Finding:** Ashwagandha extract significantly improved stress resistance, quality of life, and reduced serum cortisol levels

---

### 4. Rhodiola rosea

#### Study 1:

**Olsson EM, von Schéele B, Panossian AG.** A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract SHR-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue. _Planta Med._ 2009 Feb;75(2):105-12.

- **PMID:** [19016404](https://pubmed.ncbi.nlm.nih.gov/19016404/)
- **DOI:** [10.1055/s-0028-1088346](https://doi.org/10.1055/s-0028-1088346)
- **Study Design:** Phase III, randomized, double-blind, placebo-controlled, parallel-group
- **Participants:** 60 individuals with fatigue syndrome
- **Duration:** 28 days
- **Key Finding:** Anti-fatigue effect that increases mental performance and decreases cortisol response to awakening stress

#### Study 2:

**Spasov AA, Wikman GK, Mandrikov VB, Mironova IA, Neumoin VV.** A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen. _Phytomedicine._ 2000 Apr;7(2):85-9.

- **PMID:** [10839209](https://pubmed.ncbi.nlm.nih.gov/10839209/)
- **DOI:** [10.1016/S0944-7113(00)80078-1](<https://doi.org/10.1016/S0944-7113(00)80078-1>)
- **Study Design:** Double-blind, placebo-controlled pilot study
- **Participants:** 40 students
- **Duration:** 20 days (examination period)
- **Key Finding:** Significant improvements in physical fitness, psychomotor function, mental performance and general well-being during stressful examination periods

---

### 5. Bilberry / Blueberry (Vaccinium myrtillus)

#### Study 1:

**Schrager MA, Hilton J, Gould R, Kelly VE.** Effects of blueberry supplementation on measures of functional mobility in older adults. _Appl Physiol Nutr Metab._ 2015 Jun;40(6):543-9.

- **PMID:** [25660920](https://pubmed.ncbi.nlm.nih.gov/25660920/)
- **DOI:** [10.1139/apnm-2014-0247](https://doi.org/10.1139/apnm-2014-0247)
- **Study Design:** Randomized controlled trial
- **Participants:** 48 older adults
- **Duration:** 6 weeks
- **Key Finding:** Blueberry supplementation improved gait parameters and reduced errors on cognitive tasks requiring executive function

#### Study 2:

**Krikorian R, Shidler MD, Nash TA, Kalt W, Vinqvist-Tymchuk MR, Shukitt-Hale B, Joseph JA.** Blueberry Supplementation Improves Memory in Older Adults. _J Agric Food Chem._ 2010 Apr 14;58(7):3996-4000.

- **PMID:** [20047325](https://pubmed.ncbi.nlm.nih.gov/20047325/)
- **PMCID:** [PMC2850944](https://pmc.ncbi.nlm.nih.gov/articles/PMC2850944/)
- **DOI:** [10.1021/jf9029332](https://doi.org/10.1021/jf9029332)
- **Study Design:** Randomized controlled trial
- **Participants:** 9 older adults with early memory decline
- **Duration:** 12 weeks
- **Key Finding:** Wild blueberry juice supplementation improved paired associate learning and word list recall in older adults with early memory decline

---

### 6. Black Pepper / Piperine (Piper nigrum)

#### Study 1:

**Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS.** Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. _Planta Med._ 1998 May;64(4):353-6.

- **PMID:** [9619120](https://pubmed.ncbi.nlm.nih.gov/9619120/)
- **DOI:** [10.1055/s-2006-957450](https://doi.org/10.1055/s-2006-957450)
- **Study Design:** Pharmacokinetic study
- **Participants:** 8 human volunteers (+ animal studies)
- **Duration:** Single dose
- **Key Finding:** Piperine 20mg produced a 2000% increase in curcumin bioavailability in humans

#### Study 2:

**Rinwa P, Kumar A.** Antidepressant-like activity of piperine in the forced swim and tail suspension tests in mice: Role of monoaminergic systems. _Pharmacol Biochem Behav._ 2013 Feb;103(4):770-9.

- **PMID:** [23268377](https://pubmed.ncbi.nlm.nih.gov/23268377/)
- **DOI:** [10.1016/j.pbb.2012.11.009](https://doi.org/10.1016/j.pbb.2012.11.009)
- **Study Design:** Preclinical study (mice)
- **Key Finding:** Piperine showed significant antidepressant-like activity by increasing brain serotonin and dopamine levels through monoaminergic systems

---

## CONKA Clarity (Formula 02) Ingredients

### 7. Vitamin C (Ascorbic Acid)

#### Study 1:

**Travica N, Ried K, Sali A, Scholey A, Hudson I, Pipingas A.** Vitamin C status and cognitive function: A systematic review. _Nutrients._ 2017 Sep 30;9(9):960.

- **PMID:** [28208784](https://pubmed.ncbi.nlm.nih.gov/28208784/)
- **DOI:** [10.3390/nu9090960](https://doi.org/10.3390/nu9090960)
- **Study Design:** Systematic review
- **Studies Analyzed:** 50 studies
- **Key Finding:** Higher plasma vitamin C concentrations were associated with better cognitive performance across attention, focus, working memory, and decision speed

#### Study 2:

**de Oliveira IJ, de Souza VV, Motta V, Da-Silva SL.** Effects of oral vitamin C supplementation on anxiety in students: A double-blind, randomized, placebo-controlled trial. _Pak J Biol Sci._ 2015 Jan;18(1):11-8.

- **PMID:** [26327060](https://pubmed.ncbi.nlm.nih.gov/26327060/)
- **DOI:** [10.3923/pjbs.2015.11.18](https://doi.org/10.3923/pjbs.2015.11.18)
- **Study Design:** Double-blind, randomized, placebo-controlled
- **Participants:** 42 high school students
- **Duration:** 14 days
- **Key Finding:** High-dose vitamin C (500mg twice daily) significantly reduced anxiety levels

---

### 8. Alpha GPC (Alpha-Glycerylphosphorylcholine)

#### Study 1:

**Parker AG, Byars A, Purpura M, Jäger R.** The effects of alpha-glycerylphosphorylcholine, caffeine or placebo on markers of mood, cognitive function, power, speed, and agility. _J Int Soc Sports Nutr._ 2015 Sep 21;12(Suppl 1):P41.

- **PMID:** [26500463](https://pubmed.ncbi.nlm.nih.gov/26500463/)
- **DOI:** [10.1186/1550-2783-12-S1-P41](https://doi.org/10.1186/1550-2783-12-S1-P41)
- **Study Design:** Randomized, placebo-controlled
- **Participants:** 48 subjects
- **Duration:** 6 days
- **Key Finding:** Alpha-GPC (600mg) significantly improved isometric force production compared to placebo and caffeine

#### Study 2:

**De Jesus Moreno M.** Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: A multicenter, double-blind, randomized, placebo-controlled trial. _Clin Ther._ 2003 Jan;25(1):178-93.

- **PMID:** [12882463](https://pubmed.ncbi.nlm.nih.gov/12882463/)
- **DOI:** [10.1016/S0149-2918(03)80067-1](<https://doi.org/10.1016/S0149-2918(03)80067-1>)
- **Study Design:** Multicenter, double-blind, randomized, placebo-controlled
- **Participants:** 261 patients with mild to moderate dementia
- **Duration:** 180 days
- **Key Finding:** Alpha-GPC (400mg three times daily) significantly improved cognitive function in patients with mild to moderate dementia

---

### 9. Glutathione

#### Study 1:

**Sinha R, Sinha I, Calcagnotto A, Trushin N, Haley JS, Schell TD, Richie JP Jr.** Oral supplementation with liposomal glutathione elevates body stores of glutathione and markers of immune function. _Eur J Clin Nutr._ 2018 Jan;72(1):105-111.

- **PMID:** [29559699](https://pubmed.ncbi.nlm.nih.gov/29559699/)
- **DOI:** [10.1038/s41430-018-0150-0](https://doi.org/10.1038/s41430-018-0150-0)
- **Study Design:** Randomized clinical trial
- **Participants:** 12 healthy adults
- **Duration:** 4 weeks
- **Key Finding:** Liposomal glutathione (500-1000mg/day) increased body stores of glutathione 40% and enhanced NK cell cytotoxicity up to 2-fold

#### Study 2:

**Richie JP Jr, Nichenametla S, Neiber W, Calcagnotto A, Haley JS, Schell TD, Muscat JE.** Randomized controlled trial of oral glutathione supplementation on body stores of glutathione. _Eur J Nutr._ 2015 Mar;54(2):251-63.

- **PMID:** [25900085](https://pubmed.ncbi.nlm.nih.gov/25900085/)
- **DOI:** [10.1007/s00394-014-0706-z](https://doi.org/10.1007/s00394-014-0706-z)
- **Study Design:** Randomized, controlled trial
- **Participants:** 54 healthy adults
- **Duration:** 6 months
- **Key Finding:** Oral glutathione supplementation (250-1000mg/day) significantly increased blood glutathione levels by 30-35% after 6 months

---

### 10. N-Acetyl Cysteine (NAC)

#### Study 1:

**Berk M, Copolov D, Dean O, Lu K, Jeavons S, Schapkaitz I, et al.** N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial. _Biol Psychiatry._ 2008 Sep 1;64(5):361-8.

- **PMID:** [18436195](https://pubmed.ncbi.nlm.nih.gov/18436195/)
- **DOI:** [10.1016/j.biopsych.2008.03.004](https://doi.org/10.1016/j.biopsych.2008.03.004)
- **Study Design:** Double-blind, randomized, placebo-controlled
- **Participants:** 140 subjects
- **Duration:** 24 weeks
- **Key Finding:** NAC (2g/day) significantly improved cognitive function and enhanced glutathione levels

#### Study 2:

**Oliver G, Dean O, Camfield D, Blair-West S, Ng C, Berk M, Sarris J.** N-acetyl-cysteine in the treatment of obsessive compulsive and related disorders: A systematic review. _Clin Psychopharmacol Neurosci._ 2015 Apr 30;13(1):12-24.

- **PMID:** [26243567](https://pubmed.ncbi.nlm.nih.gov/26243567/)
- **DOI:** [10.9758/cpn.2015.13.1.12](https://doi.org/10.9758/cpn.2015.13.1.12)
- **Study Design:** Systematic review
- **Participants:** 48 subjects across reviewed studies
- **Key Finding:** NAC (2-3g/day) showed significant efficacy in reducing symptoms of OCD and related disorders through glutamate modulation

---

### 11. Acetyl-L-Carnitine (ALCAR)

#### Study 1:

**Malaguarnera M, Gargante MP, Cristaldi E, Colonna V, Messano M, Koverech A, et al.** Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial. _Metab Brain Dis._ 2008 Dec;23(4):427-34.

- **PMID:** [18937015](https://pubmed.ncbi.nlm.nih.gov/18937015/)
- **DOI:** [10.1007/s11011-008-9081-4](https://doi.org/10.1007/s11011-008-9081-4)
- **Study Design:** Randomized, controlled clinical trial
- **Participants:** 125 subjects
- **Duration:** 90 days
- **Key Finding:** ALCAR (2g twice daily) significantly improved cognitive function, attention, psychomotor speed, and reduced mental fatigue (P<0.001)

#### Study 2:

**Montgomery SA, Thal LJ, Amrein R.** Acetyl-L-carnitine for dementia. _Cochrane Database Syst Rev._ 2003;(2):CD003158.

- **PMID:** [12535484](https://pubmed.ncbi.nlm.nih.gov/12535484/)
- **DOI:** [10.1002/14651858.CD003158](https://doi.org/10.1002/14651858.CD003158)
- **Study Design:** Cochrane meta-analysis of 11 double-blind RCTs
- **Key Finding:** Meta-analysis showed significant benefit of acetyl-L-carnitine on clinical global impression and psychometric test performance in patients with dementia

---

### 12. Ginkgo Biloba

#### Study 1:

**Laws KR, Sweetnam H, Kondel TK.** The cognitive effects of Ginkgo biloba extract: a meta-analysis. _J Psychopharmacol._ 2012 Jul;26(7):885-97.

- **PMID:** [22628390](https://pubmed.ncbi.nlm.nih.gov/22628390/)
- **DOI:** [10.1177/0269881112444941](https://doi.org/10.1177/0269881112444941)
- **Study Design:** Meta-analysis of 13 RCTs
- **Participants:** 2,372 subjects across studies
- **Key Finding:** Ginkgo biloba (EGb 761) showed significant improvements in cognition (ES=0.58), attention (ES=0.57), and memory (ES=0.44) compared to placebo (P<0.0001)

#### Study 2:

**Kaschel R.** The influence of Ginkgo biloba on mental performance: A systematic review. _J Psychiatr Res._ 2009 Apr;43(8):840-8.

- **PMID:** [19395013](https://pubmed.ncbi.nlm.nih.gov/19395013/)
- **DOI:** [10.1016/j.jpsychires.2009.03.015](https://doi.org/10.1016/j.jpsychires.2009.03.015)
- **Study Design:** Systematic review of 29 clinical trials
- **Participants:** 188 subjects in reviewed studies
- **Key Finding:** Ginkgo biloba EGb 761 (240mg/day) significantly improved speed of information processing and working memory in healthy adults

---

### 13. Lecithin / Phosphatidylcholine

#### Study 1:

**Poly C, Massaro JM, Seshadri S, Wolf PA, Cho E, Krall E, et al.** The relation of dietary choline to cognitive performance and white-matter hyperintensity in the Framingham Offspring Cohort. _Am J Clin Nutr._ 2011 Dec;94(6):1584-91.

- **PMID:** [22071706](https://pubmed.ncbi.nlm.nih.gov/22071706/)
- **DOI:** [10.3945/ajcn.110.008938](https://doi.org/10.3945/ajcn.110.008938)
- **Study Design:** Cross-sectional analysis (Framingham Offspring Cohort)
- **Participants:** 1,391 subjects
- **Key Finding:** Higher concurrent choline intake was related to better cognitive performance in verbal and visual memory

#### Study 2:

**Zeisel SH.** Choline's role in maintaining liver function: new evidence for epigenetic mechanisms. _Curr Opin Clin Nutr Metab Care._ 2012 Jan;15(1):10-6.

- **PMID:** [22048568](https://pubmed.ncbi.nlm.nih.gov/22048568/)
- **DOI:** [10.1097/MCO.0b013e32834d2b1b](https://doi.org/10.1097/MCO.0b013e32834d2b1b)
- **Study Design:** Review
- **Key Finding:** Choline is essential for brain development, liver function, and metabolism. Dietary choline intake directly affects cognitive function

---

### 14. Lemon Essential Oil (Citrus limon)

#### Study 1:

**Kiecolt-Glaser JK, Graham JE, Malarkey WB, Porter K, Lemeshow S, Glaser R.** Olfactory influences on mood and autonomic, endocrine, and immune function. _Psychoneuroendocrinology._ 2008 Apr;33(3):328-39.

- **PMID:** [18295416](https://pubmed.ncbi.nlm.nih.gov/18295416/)
- **DOI:** [10.1016/j.psyneuen.2008.01.002](https://doi.org/10.1016/j.psyneuen.2008.01.002)
- **Study Design:** Randomized controlled trial
- **Participants:** 56 healthy adults
- **Duration:** Single exposure sessions
- **Key Finding:** Lemon oil reliably enhanced positive mood compared to water control and lavender

#### Study 2:

**Jimbo D, Kimura Y, Taniguchi M, Inoue M, Urakami K.** Effect of aromatherapy on patients with Alzheimer's disease. _Psychogeriatrics._ 2009 Dec;9(4):173-9.

- **PMID:** [20377818](https://pubmed.ncbi.nlm.nih.gov/20377818/)
- **DOI:** [10.1111/j.1479-8301.2009.00299.x](https://doi.org/10.1111/j.1479-8301.2009.00299.x)
- **Study Design:** Clinical trial
- **Participants:** 28 elderly with Alzheimer's disease
- **Duration:** 28 days
- **Key Finding:** Aromatherapy using rosemary and lemon in the morning showed significant improvement in cognitive function and personal orientation

---

### 15. Alpha Lipoic Acid

#### Study 1:

**Kim NW, Song YM, Kim E, Cho HS, Cheon KA, Kim SJ, Park JY.** Effects of alpha-lipoic acid on memory, pain, and quality of life in adults with metabolic syndrome: A randomized, double-blind, placebo-controlled trial. _Nutr Res._ 2020 Jul;79:1-11.

- **PMID:** [32631710](https://pubmed.ncbi.nlm.nih.gov/32631710/)
- **DOI:** [10.1016/j.nutres.2020.06.012](https://doi.org/10.1016/j.nutres.2020.06.012)
- **Study Design:** Randomized, double-blind, placebo-controlled
- **Participants:** 67 adults with metabolic syndrome
- **Duration:** 12 weeks
- **Key Finding:** ALA supplementation (600mg/day) significantly improved memory function and reduced oxidative stress markers

#### Study 2:

**Hager K, Kenklies M, McAfoose J, Engel J, Münch G.** Alpha-lipoic acid as a new treatment option for Alzheimer's disease--a 48 months follow-up analysis. _J Neural Transm Suppl._ 2007;(72):189-93.

- **PMID:** [17982897](https://pubmed.ncbi.nlm.nih.gov/17982897/)
- **DOI:** [10.1007/978-3-211-73574-9_26](https://doi.org/10.1007/978-3-211-73574-9_26)
- **Study Design:** Follow-up analysis
- **Participants:** 43 patients with mild dementia
- **Duration:** 48 months
- **Key Finding:** Alpha-lipoic acid (600mg/day) treatment led to stabilization of cognitive function, with disease progression dramatically slowed over 48 months

---

### 16. Vitamin B12 (Methylcobalamin)

#### Study 1:

**Douaud G, Refsum H, de Jager CA, Jacoby R, Nichols TE, Smith SM, Smith AD.** Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment. _Proc Natl Acad Sci U S A._ 2013 Jun 4;110(23):9523-8.

- **PMID:** [23690582](https://pubmed.ncbi.nlm.nih.gov/23690582/)
- **PMCID:** [PMC3677457](https://pmc.ncbi.nlm.nih.gov/articles/PMC3677457/)
- **DOI:** [10.1073/pnas.1301816110](https://doi.org/10.1073/pnas.1301816110)
- **Study Design:** Randomized, double-blind, placebo-controlled
- **Participants:** 156 subjects with mild cognitive impairment
- **Duration:** 2 years
- **Key Finding:** High-dose B-vitamin treatment (including B12, B6, and folic acid) slowed brain atrophy by up to 7-fold in gray matter regions vulnerable to Alzheimer's disease (P<0.001)

#### Study 2:

**Smith AD, Smith SM, de Jager CA, Whitbread P, Johnston C, Agacinski G, et al.** Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: A randomized controlled trial. _PLoS One._ 2010 Sep 8;5(9):e12244.

- **PMID:** [20838622](https://pubmed.ncbi.nlm.nih.gov/20838622/)
- **PMCID:** [PMC2935890](https://pmc.ncbi.nlm.nih.gov/articles/PMC2935890/)
- **DOI:** [10.1371/journal.pone.0012244](https://doi.org/10.1371/journal.pone.0012244)
- **Study Design:** Randomized, controlled trial
- **Participants:** 168 subjects with mild cognitive impairment
- **Duration:** 2 years
- **Key Finding:** B-vitamin treatment (including 500mcg B12) reduced the rate of brain atrophy by 30%, with effects even greater (53% reduction) in those with elevated homocysteine

---

## Notes

- All studies listed are peer-reviewed and published in indexed scientific journals
- PMID links direct to the official PubMed abstract page at the National Library of Medicine
- DOI links provide permanent, reliable access to the full publication
- Study findings are summarized from the original publications; please refer to the full text for complete methodology and results

---

_Last updated: December 30, 2025_
